← Back to Patent Explorer
US4259329A Expired / Lapsed US ⏱️ 0.0 years remaining

17-Cyclobutylmethyl-3-hydroxy-β-methyl-6-methylene morphinane, and methods of treating pain with them

Assignee: Bayer Corp
•
Filing: 1980-04-21
•
Granted: 1981-03-31
•
Expires: 2000-04-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 6-methylene-morphinan compounds corresponding to the formula: ##STR1## wherein R 1 and R 3 are H or methyl and R 2 is cyclopropylmethyl or cyclobutylmethyl. These compounds are useful as mixed analgesics/narcotic antagonists.

Inventors

  • 👤 Michael P. Kotick
  • 👤 Joseph O. Polazzi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 22:20
CPC Classifications
C; C07; C07D; C07D221/00; C07D221/02; C07D221/22; C07D221/28

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 6 words
17-cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene morphinane of the formula: ##STR10##
Claim 2
Dependent Claim 6 words
17-cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene morphinane of the formula: ##STR10##
Claim 3
Dependent Claim 16 words
The compound of claim 1 in the form of its nontoxic, pharmaceutically acceptable acid addition salt.
Claim 4
Dependent Claim 18 words
The compound of claim 1 which is in the form of the tartrate, hydrobromide, hydrochloride or maleate salt.
Claim 5
Dependent Claim 29 words
A therapeutic method of treating pain in an individual requiring such treatment which comprises administering to such individual an effective amount of a compound characterized by the formula: ##STR11##
Claim 6
Dependent Claim 29 words
A therapeutic method of treating pain in an individual requiring such treatment which comprises administering to such individual an effective amount of a compound characterized by the formula: ##STR11##
Claim 7
Dependent Claim 22 words
The method of claim 4 in which the compound is administered in the form of its nontoxic, pharmaceutically acceptable acid addition salt.
Claim 8
Dependent Claim 20 words
The method of claim 4 wherein the compound is in the form of its tartrate, hydrobromide, hydrochloride or maleate salt.

References Cited (Backward Citations)

US3285922A Cited
US3654280A Cited
US3738989A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-30 1984-09-29 1985-03-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-30 1988-09-29 1989-03-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-30 1992-09-29 1993-03-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag